Novavax Offers U.S. a Fourth Strong Covid-19 Vaccine
The New York Times
The company’s large U.S. trial found an efficacy rate of about 90 percent. But at this point, the nation is awash in other shots.
Novavax, a small American company buoyed by lavish support from the U.S. government, announced on Monday the results of a clinical trial of its Covid-19 vaccine in the United States and Mexico, finding that its two-shot inoculation provides potent protection against the coronavirus. In the 29,960-person trial, the vaccine demonstrated an overall efficacy of 90.4 percent, on par with the vaccines made by Pfizer-BioNTech and Moderna, and higher than the one-shot vaccine from Johnson & Johnson. The Novavax vaccine showed an efficacy of 100 percent at preventing moderate or severe disease. Despite these impressive results, the vaccine’s future in the United States is uncertain and it might be needed more in other countries. Novavax says it may not seek emergency authorization from the Food and Drug Administration until the end of September. And with a plentiful supply of three other authorized vaccines, it’s possible that the agency may tell Novavax to apply instead for a full license — a process that could require several extra months.
Some women are stocking up on the medications, saying they are concerned that the new administration could take steps to restrict access.
As the glaciers of South America retreat, the supply of freshwater is dwindling and its quality is getting worse.
It’s something turkey often isn’t — undeniably juicy and a guaranteed crowd-pleaser.
A rise in the disease in younger people was not followed by an increase in deaths, a study found, and might be a sign of overdiagnosis.
The Homotherium cub was preserved in Siberian permafrost with its dark fur and flesh intact.
A small study found ChatGPT outdid human physicians when assessing medical case histories, even when those doctors were using a chatbot.
For a century, exoplanet hunters have “discovered” planets around a nearby star, only to retract the claims. But the latest find is for real.
The unidentified patient had recently returned from Africa, where the virus has caused a deadly epidemic, health officials said.
The event produces some of the year’s fastest meteors, although the nearly full moon may make them challenging to spot.
Mr. Musk dug into his companies’ budgets, preferring to cut too much rather than too little and to deal with the fallout later. Under Donald Trump, he is set to apply those tactics to the U.S. government.
Behind the scenes at a Chicago zoo, chimpanzees who spent years entertaining humans are learning to befriend their own kind.